Literature DB >> 23739664

'INSPIRED' approaches to better care for patients with advanced COPD.

Graeme M Rocker1, Deborah Cook.   

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is the most common cause of admission to acute care facilities in Canada. The burden of illness for patients, caregivers and the health care system is profound. Dyspnea in advanced COPD pervades all aspects of patients' lives. When increasing symptom burden limits patients to their homes, crucial primary care services become less accessible, and care of end-stage COPD becomes increasingly fragmented and reactive. Given the considerable physical and psychosocial consequences of advanced COPD, this phase can be devastating for patients and families. In this article we outline the need for clinical interventions and re-organized models of care designed for better continuity to achieve more favorable outcomes for these patients and their families. Outreach programs and use of personalized action plans that include advice on careful use of opioids can be remarkably effective. The move toward an integrated approach to COPD management with more effective advance care planning will help patients and their families make informed decisions throughout the illness trajectory. Intensive medical treatment focused on increasing survival can coexist with both holistic and palliative approaches to improve the quality of life of patients with severe end-stage COPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739664     DOI: 10.25011/cim.v36i3.19721

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  9 in total

Review 1.  The Role of Palliative Care in COPD.

Authors:  Anand S Iyer; Donald R Sullivan; Kathleen O Lindell; Lynn F Reinke
Journal:  Chest       Date:  2021-11-03       Impact factor: 10.262

2.  Spreading improvements for advanced COPD care through a Canadian Collaborative.

Authors:  Graeme M Rocker; Claudia Amar; Wendy L Laframboise; Jane Burns; Jennifer Y Verma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-26

Review 3.  Improving care for advanced COPD through practice change: Experiences of participation in a Canadian spread collaborative.

Authors:  Jennifer Y Verma; Claudia Amar; Shannon Sibbald; Graeme M Rocker
Journal:  Chron Respir Dis       Date:  2017-06-14       Impact factor: 2.444

4.  Integrated respiratory and palliative care may improve outcomes in advanced lung disease.

Authors:  Natasha Smallwood; Michelle Thompson; Matthew Warrender-Sparkes; Peter Eastman; Brian Le; Louis Irving; Jennifer Philip
Journal:  ERJ Open Res       Date:  2018-02-16

5.  Exploring role clarity in interorganizational spread and scale-up initiatives: the 'INSPIRED' COPD collaborative.

Authors:  Olivia Ly; Shannon L Sibbald; Jennifer Y Verma; Graeme M Rocker
Journal:  BMC Health Serv Res       Date:  2018-09-03       Impact factor: 2.655

Review 6.  Improving the quality of life of people with advanced respiratory disease and severe breathlessness.

Authors:  Sara Booth; Miriam J Johnson
Journal:  Breathe (Sheff)       Date:  2019-09

7.  Feasibility and acceptability of introducing advance care planning on a thoracic medicine inpatient ward: an exploratory mixed method study.

Authors:  Nina Elisabeth Hjorth; Margrethe Aase Schaufel; Katrin Ruth Sigurdardottir; Dagny R Faksvåg Haugen
Journal:  BMJ Open Respir Res       Date:  2020-02

8.  The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial.

Authors:  Morag C Farquhar; A Toby Prevost; Paul McCrone; Barbara Brafman-Price; Allison Bentley; Irene J Higginson; Chris J Todd; Sara Booth
Journal:  Trials       Date:  2016-04-04       Impact factor: 2.279

Review 9.  Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches.

Authors:  Hai-Xia Zhou; Xue-Mei Ou; Yong-Jiang Tang; Lan Wang; Yu-Lin Feng
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.